Biologics and biosimilars

Biosimilars in Oncology: From Development to Clinical Practice

(2014) Katherine H. Rak Tkaczuk et al.   SEMINARS IN ONCOLOGY

Evaluating the inter and intra batch variability of protein aggregation behaviour using Taylor dispersion analysis and dynamic light scattering

(2013) Wendy L. Hulse et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Biosimilars: Impact of Biologic Product Life Cycle and European Experience on the Regulatory Trajectory in the United States

(2012) Islah Ahmed et al.   CLINICAL THERAPEUTICS

Biosimilar rhG-CSFs: how similar are they?

(2012) Patricia Gravel et al.   Targeted Oncology

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

(2011) Martin Schiestl et al.   NATURE BIOTECHNOLOGY

How Innovative Technology Is Moving Biologics Into the 21st Century

(2010) D K Robinson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Biosimilars – Science, status, and strategic perspective

(2009) Georg-Burkhard Kresse   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Biosimilars approval process

(2009) Leyre Zuñiga et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY